HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$38.11
Day range
$38.25 - $40.84
Year range
$5.83 - $41.00
Market cap
2.09B USD
Avg Volume
487.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.18M | 76.79% |
Net income | -51.50M | -33.40% |
Net profit margin | — | — |
Earnings per share | -1.22 | 75.70% |
EBITDA | -47.57M | -16.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 290.88M | -24.80% |
Total assets | 322.02M | -20.18% |
Total liabilities | 125.59M | 185.45% |
Total equity | 196.43M | — |
Shares outstanding | 53.68M | — |
Price to book | 8.20 | — |
Return on assets | -38.68% | — |
Return on capital | -54.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -51.50M | -33.40% |
Cash from operations | -41.12M | -32.41% |
Cash from investing | 40.04M | 249.64% |
Cash from financing | 72.62M | -68.96% |
Net change in cash | 71.56M | -59.37% |
Free cash flow | -28.47M | -42.04% |
About
Founded
2019
Headquarters
Website
Employees
130
